Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1751-1760 of 1772 for

Edit search filters
  1. A Study Identifying Predictive Biomarkers For The Progression Of Invasive Squamous Cell Carcinoma

    Rochester, MN

  2. Imaging Of Prostatic Anatomy In Patients With Known Prostate Cancer And Those At High-Risk Using Magnetic Resonance Elastography

    Rochester, MN

  3. Defining The Immunologic Profile Of Sentinel Lymph Nodes And Identifying The Mechanisms Responsible For Immunosuppression

    Jacksonville, FL, Rochester, MN

  4. Circulating Tumor Cells In Patients With Cholangiocarcinoma

    Rochester, MN

  5. A Study To Evaluate DNA Evaluation Of Fragments For Early Interception - Lung Cancer Training Study

    Rochester, MN

  6. A Study To Evaluate Economic And Clinical Outcomes Of Whole Exome Sequencing

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Evaluation Of A Mixed Meal Test For Diagnosis And Characterization And Type 3c Diabetes Mellitus Secondary To Pancreatic Cancer And Chronic Pancreatitis (DETECT)

    Rochester, MN

  8. Blood And Urine Identification Of Methylated DNA Markers In Invasive Bladder Carcinoma

    Rochester, MN

  9. ROF2181

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Detection Of Circulating Tumor Cells (CTC) From Patients With Hepatocellular Carcinoma (HCC)

    Rochester, MN

.

Mayo Clinic Footer